Serena Fasano

1.7k total citations · 1 hit paper
45 papers, 995 citations indexed

About

Serena Fasano is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Serena Fasano has authored 45 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 15 papers in Immunology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Serena Fasano's work include Systemic Lupus Erythematosus Research (31 papers), Atherosclerosis and Cardiovascular Diseases (10 papers) and Systemic Sclerosis and Related Diseases (10 papers). Serena Fasano is often cited by papers focused on Systemic Lupus Erythematosus Research (31 papers), Atherosclerosis and Cardiovascular Diseases (10 papers) and Systemic Sclerosis and Related Diseases (10 papers). Serena Fasano collaborates with scholars based in Italy, United Kingdom and Switzerland. Serena Fasano's co-authors include Francesco Ciccia, David Isenberg, Gabriele Valentini, Giuliana Guggino, Giulia Grasso, Lidia La Barbera, Chiara Rizzo, Claudia Schinocca, Michele Iudici and Ilenia Pantano and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Serena Fasano

41 papers receiving 978 citations

Hit Papers

Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serena Fasano Italy 19 601 425 156 147 138 45 995
Elena Elefante Italy 19 644 1.1× 312 0.7× 141 0.9× 132 0.9× 57 0.4× 72 1.0k
Fengchun Zhang China 20 440 0.7× 307 0.7× 198 1.3× 145 1.0× 215 1.6× 68 1.3k
Gráinne Murphy Ireland 15 771 1.3× 598 1.4× 181 1.2× 254 1.7× 105 0.8× 38 1.4k
Szilvia Szamosi Hungary 20 386 0.6× 286 0.7× 338 2.2× 235 1.6× 158 1.1× 58 1.0k
Mohammed Akil United Kingdom 17 607 1.0× 461 1.1× 193 1.2× 251 1.7× 71 0.5× 45 1.2k
Xiaomei Leng China 15 408 0.7× 417 1.0× 92 0.6× 101 0.7× 49 0.4× 79 855
Takahiko Sugihara Japan 16 488 0.8× 279 0.7× 101 0.6× 227 1.5× 286 2.1× 72 1.0k
Mercedes Alperí Spain 25 744 1.2× 595 1.4× 120 0.8× 245 1.7× 90 0.7× 91 1.3k
Chanyuan Wu China 19 513 0.9× 191 0.4× 125 0.8× 210 1.4× 355 2.6× 67 964

Countries citing papers authored by Serena Fasano

Since Specialization
Citations

This map shows the geographic impact of Serena Fasano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Fasano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Fasano more than expected).

Fields of papers citing papers by Serena Fasano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Fasano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Fasano. The network helps show where Serena Fasano may publish in the future.

Co-authorship network of co-authors of Serena Fasano

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Fasano. A scholar is included among the top collaborators of Serena Fasano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Fasano. Serena Fasano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizzo, Chiara, Lidia La Barbera, Marianna Lo Pizzo, et al.. (2025). Potential involvement of IL-40 in kidney disease associated to systemic lupus erythematosus. Lupus. 34(11). 1178–1183.
2.
Trentin, Francesca, Chiara Tani, Alberto Cauli, et al.. (2023). AB0558 ANIFROLUMAB IN REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS: A REAL-LIFE, MULTICENTER STUDY. Annals of the Rheumatic Diseases. 82. 1476–1476. 2 indexed citations
3.
Fasano, Serena, et al.. (2023). Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus. Lupus Science & Medicine. 10(1). e000841–e000841. 19 indexed citations
4.
Fasano, Serena, Ilenia Pantano, Daniele Mauro, et al.. (2021). POS1210 PREVALENCE OF COVID-19 AMONG PATIENTS WITH RHEUMATIC DISEASES: AN OBSERVATIONAL SURVEY DURING THE TWO WAVES IN ITALY. Annals of the Rheumatic Diseases. 80. 888–888. 1 indexed citations
5.
Fasano, Serena & Francesco Ciccia. (2021). Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey.. Clinical and Experimental Rheumatology. 39 Suppl 128(1). 13–13. 3 indexed citations
6.
Restivo, Vincenzo, Mario Daidone, Rosario Luca Norrito, et al.. (2021). Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus. Autoimmunity Reviews. 21(1). 102925–102925. 60 indexed citations
7.
Fasano, Serena, et al.. (2020). <p>Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?</p>. ImmunoTargets and Therapy. Volume 9. 105–110. 34 indexed citations
8.
Mauro, Daniele, et al.. (2019). ILC3 in Axial Spondyloarthritis: the Gut Angle. Current Rheumatology Reports. 21(7). 37–37. 32 indexed citations
9.
Riccardi, Antonella, Antonella Marcoccia, Tiziana Guastafierro, et al.. (2019). Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolve. Autoimmunity Reviews. 18(9). 102358–102358. 7 indexed citations
10.
Fasano, Serena, et al.. (2019). Subclinical Pancreatitis as Onset of Systemic Lupus Erythematosus. JCR Journal of Clinical Rheumatology. 27(8S). S520–S524. 3 indexed citations
11.
Fasano, Serena & David Isenberg. (2019). Present and novel biologic drugs in primary Sjögren's syndrome.. PubMed. 37 Suppl 118(3). 167–174. 18 indexed citations
12.
Iacono, Daniela, Elvira Favoino, Serena Fasano, et al.. (2018). Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence. Open Access Rheumatology Research and Reviews. Volume 10. 129–134. 2 indexed citations
14.
Riccardi, Antonella, Michele Iudici, Serena Fasano, et al.. (2017). Lung involvement in “stable” undifferentiated connective tissue diseases: a rheumatology perspective. Clinical Rheumatology. 36(8). 1833–1837. 3 indexed citations
16.
Iacono, Daniela, et al.. (2017). Mortality in Italian patients with rheumatoid arthritis: evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center. Open Access Rheumatology Research and Reviews. Volume 9. 185–189. 1 indexed citations
17.
Fasano, Serena, Patrick Gordon, R. Hajji, Esthela Loyo, & David Isenberg. (2016). Rituximab in the treatment of inflammatory myopathies: a review. Lara D. Veeken. 56(1). 26–36. 84 indexed citations
18.
Fasano, Serena, et al.. (2016). Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review. Lupus. 25(14). 1509–1519. 37 indexed citations
19.
Iudici, Michele, Serena Fasano, Ilenia Pantano, et al.. (2016). Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study. Lara D. Veeken. 55(9). 1623–1630. 29 indexed citations
20.
Iudici, Michele, Serena Fasano, Daniela Iacono, et al.. (2013). Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries. Clinical Rheumatology. 33(2). 153–164. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026